Catalyst Wire Dossier Catalyst Wire Dossier

aribulin

halichondrin B analog
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for aribulin, covering 2023-07-28 to 2023-07-28. Get the full timeline:

Most recent: Clinical Trial Update: Aribulin Combined With Carboplatin and Bevacizumab in the Treatment of Ovarian Cancer [Phase 1, Phase 2]

See pricing